Contradictory to these data, Hu et al. reported that siRNA mediated downregulation of XPC was associated with increased cisplatin resistance of two colon cancer cell lines and XPC overexpression led to drug sensitivity [38]. The gene discussed is XPC; the disease is colonic neoplasm.